GOSSAMER BIO, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $315.0K |
| Mar 2018 | — | — | $79.2M |
| Jun 2018 | — | — | $32.3M |
| Sep 2018 | — | — | $141.3M |
| Dec 2018 | $21.1M | $239.4M | $105.2M |
| Mar 2019 | $35.7M | $515.9M | $170.8M |
| Jun 2019 | $65.7M | $507.2M | $148.5M |
| Sep 2019 | $70.9M | $469.8M | $130.7M |
| Dec 2019 | $74.1M | $426.6M | $135.0M |
| Mar 2020 | $65.0M | $371.5M | $111.4M |
| Jun 2020 | $204.8M | $625.1M | $486.1M |
| Sep 2020 | $212.1M | $584.2M | $462.0M |
| Dec 2020 | $218.7M | $539.4M | $486.1M |
| Mar 2021 | $210.4M | $482.5M | $439.7M |
| Jun 2021 | $211.8M | $432.5M | $342.5M |
| Sep 2021 | $217.2M | $387.0M | $213.5M |
| Dec 2021 | $222.2M | $343.7M | $183.4M |
| Mar 2022 | $264.5M | $294.7M | $138.9M |
| Jun 2022 | $262.3M | $245.8M | $94.3M |
| Sep 2022 | $267.2M | $323.5M | $153.5M |
| Dec 2022 | $260.4M | $272.5M | $112.0M |
| Mar 2023 | $248.4M | $219.9M | $65.2M |
| Jun 2023 | $244.5M | $181.7M | $37.0M |
| Sep 2023 | $243.3M | $347.9M | $82.6M |
| Dec 2023 | $249.1M | $311.9M | $32.1M |
| Mar 2024 | $232.6M | $259.4M | $38.9M |
| Jun 2024 | $291.9M | $373.4M | $86.9M |
| Sep 2024 | $296.7M | $350.9M | $28.5M |
| Dec 2024 | $285.8M | $315.3M | $46.1M |
| Mar 2025 | $286.8M | $280.6M | $29.0M |
| Jun 2025 | $287.0M | $240.9M | $26.3M |
| Sep 2025 | $291.2M | $208.8M | $8.9M |
| Dec 2025 | $295.0M | $172.2M | $37.7M |
| Mar 2026 | $290.4M | $128.9M | $41.0M |
| Jun 2026 | $170.9M | $76.9M | $41.1M |